Jun 15, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
FDA Reviewing Preliminary Safety Information On Actos (pioglitazone)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2311012" data-attributes="member: 124445"><p>The U.S. Food and Drug Administration announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug. The preliminary results are based on five-year data from an ongoing, 10-year observational study by the manufacturer, Takeda Pharmaceuticals North America Inc., San Diego. These early results showed no overall association between Actos exposure and risk of bladder cancer...<a href="http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/buv06vYFsFw" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/buv06vYFsFw/3K23" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2311012, member: 124445"] The U.S. Food and Drug Administration announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug. The preliminary results are based on five-year data from an ongoing, 10-year observational study by the manufacturer, Takeda Pharmaceuticals North America Inc., San Diego. These early results showed no overall association between Actos exposure and risk of bladder cancer...[URL="http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/0/da"][IMG]http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/1/da"][IMG]http://feedads.g.doubleclick.net/~a/zqTnIsDKBeEhfVBIA8CDF-JzULE/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/buv06vYFsFw[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/buv06vYFsFw/3K23]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top